UNITED NATURAL PRODUCT ALLIANCE

  • About
    • UNPA Members >
      • Executive Members
      • Science & Technology Services Members
      • Associate Members
      • Featured Member Profiles
    • MOU Partners
    • UNPA Staff >
      • National Staff
      • Political Advisors
    • Policies & Endorsements
    • Education and Training
    • Photo Galleries >
      • Members' Retreat 2019
      • China Delegation 2018
      • UNPA 2019 Staff Retreat
    • UNPA Headquarters
    • Testimonials
  • News
    • UNPA News
    • UNPA In the News
    • Media Releases
    • Member/MOU Partner News
    • Employment Opportunities
  • Member Resources
    • Regulatory Resources >
      • GMPs >
        • Regulatory Dietary Supplements
      • FSMA >
        • PCQI
        • FSVP
      • Organics
      • Labeling/Claims >
        • Nutrition Facts label
      • Guidelines/Best Practices >
        • Monographs
      • Links and Resources
      • Global >
        • Canada
    • Member Memos
    • UNPA Digest
    • UNPA Forums
    • UNPA Presentations
    • Expert Insights Webinars
    • Education Archive
    • Exclusive Member Offers
    • Member Logos
  • Events
    • 2021 Training Schedule >
      • PCQI Training
      • GMP Inspection Training
      • FSVP Training
      • Intentional Audulteration (IA)
    • 2020 DSRS Speakers
    • Industry Calendar of Events
  • Join
  • Media
  • For Consumers
    • About Dietary Supplements
    • Dietary Supplement Caucus
    • Dietary Supplement Caucus Members
    • Additional Resources >
      • Botanical Adulteration Prevention Program
      • Integrative Medicine
      • Industry Associations
      • Terms & Acronyms
  • Contact
  • About
    • UNPA Members >
      • Executive Members
      • Science & Technology Services Members
      • Associate Members
      • Featured Member Profiles
    • MOU Partners
    • UNPA Staff >
      • National Staff
      • Political Advisors
    • Policies & Endorsements
    • Education and Training
    • Photo Galleries >
      • Members' Retreat 2019
      • China Delegation 2018
      • UNPA 2019 Staff Retreat
    • UNPA Headquarters
    • Testimonials
  • News
    • UNPA News
    • UNPA In the News
    • Media Releases
    • Member/MOU Partner News
    • Employment Opportunities
  • Member Resources
    • Regulatory Resources >
      • GMPs >
        • Regulatory Dietary Supplements
      • FSMA >
        • PCQI
        • FSVP
      • Organics
      • Labeling/Claims >
        • Nutrition Facts label
      • Guidelines/Best Practices >
        • Monographs
      • Links and Resources
      • Global >
        • Canada
    • Member Memos
    • UNPA Digest
    • UNPA Forums
    • UNPA Presentations
    • Expert Insights Webinars
    • Education Archive
    • Exclusive Member Offers
    • Member Logos
  • Events
    • 2021 Training Schedule >
      • PCQI Training
      • GMP Inspection Training
      • FSVP Training
      • Intentional Audulteration (IA)
    • 2020 DSRS Speakers
    • Industry Calendar of Events
  • Join
  • Media
  • For Consumers
    • About Dietary Supplements
    • Dietary Supplement Caucus
    • Dietary Supplement Caucus Members
    • Additional Resources >
      • Botanical Adulteration Prevention Program
      • Integrative Medicine
      • Industry Associations
      • Terms & Acronyms
  • Contact

member memos

UPDATE: The Tableting and Encapsulating Machine Regulation Act of 2018

5/21/2018

 
​Dear Colleagues --

I am pleased to share this update received from Mark Schloss (CHPA) noting that the bill (mentioned previously) to require dosage form manufacturers to register their tablet equipment is unlikely to go through mark-up, and thus chances of inclusion in any 2018 legislation is most unlikely.

See attached correspondence.
We will, of course, keep you posted. We think the threat level is certainly a DEFCON 4 or less.

Regards,

LDI


---------- Forwarded message ----------
From: Schloss, Marc <mschloss@chpa.org>
Date: Fri, May 18, 2018 at 1:21 PM
Subject: RE: The Tableting and Encapsulating Machine Regulation Act of 2018
To: Michael McGuffin <MMcguffin@ahpa.org>, Gil Roth <gil.roth@pharma-bio.org>
Cc: Bill Bookout <b.bookout@nasc.cc>, Mike Greene <MGreene@crnusa.org>, Kristen Blanchard <kblanchard@nutramaxlabs.com>, Pete Evich <pevich@vsadc.com>, "Stamoran, Cornell" <Cornell.Stamoran@catalent.com>, "Gay, John" <jgay@chpa.org>, "Spangler, David" <dSpangler@chpa.org>, Loren Israelsen <loren@unpa.com>, "Holgate, Taylor" <tholgate@chpa.org>, "Del Monte, Brent" <BDelMonte@bgrdc.com>


Dear all –​

Yesterday we received the attached, updated version of the Kustoff tableting and encapsulating bill.

Our read of the updated version of the bill is that it carves out legitimate actors so far as these legitimate parties are accurately keeping transaction records as they already are required to do by the DEA.

In terms of process, as you are all aware, the House Energy and Commerce Committee just finished their markup of 57 opioid-related bills, so it’s hard to imagine this bill being included in that package, as Kustoff has not been marked up, but we wanted to make sure you saw the latest version and our read of it.

Please let me know your thoughts,

Marc  

Marc Schloss
Vice President, Federal Government Affairs
Consumer Healthcare Products Association

1625 Eye Street, NW, Suite 600
Washington, DC 20006
Phone: (202) 429-3533
Cell: (202) 368-7448
chpa.org
 | KnowYourOTCs.org


From: Schloss, Marc 
Sent: Monday, April 23, 2018 2:55 PM
To: 'Michael McGuffin' <MMcguffin@ahpa.org>; 'Gil Roth' <gil.roth@pharma-bio.org>
Cc: 'Bill Bookout' <b.bookout@nasc.cc>; 'Mike Greene' <MGreene@crnusa.org>; 'Kristen Blanchard' <kblanchard@nutramaxlabs.com>; 'Pete Evich' <pevich@vsadc.com>; 'Stamoran, Cornell' <Cornell.Stamoran@catalent.com>; Gay, John <jgay@chpa.org>; Spangler, David <dspangler@chpa.org>; 'Loren Israelsen' <loren@unpa.com>; Holgate, Taylor <tholgate@chpa.org>; Del Monte, Brent <BDelMonte@bgrdc.com>
Subject: RE: The Tableting and Encapsulating Machine Regulation Act of 2018


All –

I wanted to let you all know that I just heard from E&C minority staff that the Kustoff bill will NOT be included in the E&C markup this week on opioids and therefore is not likely to be included in the larger opioid bill that will come out of E&C.

I will certainly pass along more as I hear it, but wanted you all to know!
Marc 

From: Schloss, Marc 
Sent: Thursday, April 5, 2018 9:03 PM
To: Michael McGuffin <MMcguffin@ahpa.org>; Gil Roth <gil.roth@pharma-bio.org>
Cc: Bill Bookout <b.bookout@nasc.cc>; Mike Greene <MGreene@crnusa.org>; Kristen Blanchard <kblanchard@nutramaxlabs.com>; Pete Evich <pevich@vsadc.com>; Stamoran, Cornell <Cornell.Stamoran@catalent.com>; Gay, John <jgay@chpa.org>; Spangler, David <dspangler@chpa.org>; Loren Israelsen <loren@unpa.com>; Holgate, Taylor <tholgate@chpa.org>
Subject: The Tableting and Encapsulating Machine Regulation Act of 2018


All –
Attached, please find the final version of this letter.
Again, thank you all for your help, guidance and assistance with this letter.
I will be sure to let you know any response we receive,
 Marc
Marc Schloss
Vice President, Federal Government Affairs
Consumer Healthcare Products Association

1625 Eye Street, NW, Suite 600
Washington, DC 20006
Phone: (202) 429-3533
Cell: (202) 368-7448
chpa.org
 | KnowYourOTCs.org


Comments are closed.
 © 2021 United Natural Products Alliance. All Rights Reserved.
Headquarters: 716 Fourth Avenue Salt Lake City, UT 84103
Mailing Address: 
6503 S Datura Street Littleton, CO 80120
801.474.2572 | info@unpa.com | homepage